Skip to main content
VCbacked
Log inGet Started

Apollo Therapeutics

Cambridge, United Kingdom

Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating medical research into medicines.

$33.5M raised
Jan 2024
Series C
BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Top Investors

Patient Square CapitalRock Springs CapitalM&G PlcUCL Technology FundReimagined Ventures

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Apollo Therapeutics

How much funding has Apollo Therapeutics raised?
Apollo Therapeutics has raised $33.5M in total funding. The most recent round was Series C. The last funding was announced in January 2024.
Who are Apollo Therapeutics's investors?
Apollo Therapeutics's investors include Patient Square Capital, Rock Springs Capital, M&G Plc, UCL Technology Fund, Reimagined Ventures.
Where is Apollo Therapeutics headquartered?
Apollo Therapeutics is headquartered in Cambridge, United Kingdom.
What does Apollo Therapeutics do?
Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating medical research into medicines.
What stage is Apollo Therapeutics at?
Apollo Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Apollo Therapeutics — Funding & Investors." VCBacked, January 2, 2024, https://www.vcbacked.co/company/apollo-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2024). Apollo Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/apollo-therapeutics
Wikipedia (cite web)
{{cite web |title=Apollo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/apollo-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M